MetaCap

Solventum Balance Sheet

NYSE: SOLVHealth CareMedical/Dental InstrumentsUSD

87.29+0.88 (+1.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Solventum financial position

At the end of fiscal 2025, Solventum reported total assets of $14.29 billion, down 1.1% from a year earlier against total liabilities of $9.24 billion. Shareholders' equity stood at $5.05 billion, or 35.3% of assets. The company held $878.0 million in cash and equivalents against $5.04 billion of debt, a net debt position of $4.16 billion.

The current ratio (current assets divided by current liabilities) was 1.23, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.00.

Summary generated from market data by MetaCap's automated system. Methodology

Solventum balance sheet (annual)

Solventum annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31
Cash & Equivalents878.00M762.00M194.00M61.00M
Receivables1.03B1.04B1.31B—
Inventory1.07B965.00M857.00M—
Total Current Assets3.86B3.25B2.52B—
Property, Plant & Equipment1.33B1.62B1.46B—
Goodwill5.70B6.38B6.54B6.43B
Intangible Assets2.59B2.54B2.90B—
Total Assets14.29B14.46B13.94B—
Accounts Payable687.00M618.00M477.00M—
Short-Term Debt0200.00M0—
Total Current Liabilities3.14B2.70B1.73B—
Long-Term Debt5.04B7.81B0—
Total Liabilities9.24B11.50B2.28B—
Shareholders' Equity5.05B2.96B11.67B11.74B
Retained Earnings1.80B242.00M0—
Total Debt5.04B8.01B0—
Net Cash (Debt)-4.16B-7.25B194.00M61.00M
Shares Outstanding173.49M172.79M0—

This table shows 4 annual periods of Solventum's balance sheet, from FY 2025 back to FY 2022, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow SOLV's reporting calendar. What is a balance sheet?

More financial data